Futureproofing supply chains in an evolving pharmaceutical industry
Pharmaceutical supply chains are some of the world’s most intricate. Recent developments have only heightened the challenges for companies on…
All articles by
-
-
Transforming CML patient monitoring with ICON’s innovative RNA-based NGS assay
Managing chronic myeloid leukemia (CML) can be challenging, especially when it comes to accurately tracking how well patients respond to…
-
Navigating clinical trial disruption: growing trends and new technologies
Disruption is a pressing problem in the pharmaceutical world; patient health depends on the smooth and predictable movement of resources…
-
Cancer therapies for young adults: The need for tailored treatment and diversity
Cancer, once primarily perceived as a disease of the elderly, is now becoming a major concern for young adults. The…
-
Minimizing risks in pharmaceutical supply chains: what you need to know
Pharmaceutical supply chains are among the world’s most complex. And for firms on the frontline, that is increasingly problematic. According…
-
A comprehensive guide to supply chain management for specialty drugs
Global demand for drugs of all kinds is increasing. GlobalData’s drugs database forecasts global drug sales, from 2024 to 2030,…
-
Enhancing mRNA drug development: how to optimise your suppliers and materials
In the wake of the Covid-19 vaccine, mRNA research and development increased dramatically. However, as the demand for Covid-19 vaccines…
-
A guide to host-cell protein analysis services for biomanufacturers
The biomanufacturing sector is undergoing a revolution. Groundbreaking therapies are opening up new frontiers in the treatment of intractable ailments…
-
The Genomic Medicine Revolution: Multi-Modality Approaches in Advanced Therapies
The landscape of genomic medicine is undergoing rapid transformation. According to a survey of hundreds of healthcare leaders conducted for…
-
Diabesity: Overlapping pathophysiology informs multi-indication treatment
The striking overlap between type 2 diabetes and obesity reflects the convergence in the underlying pathophysiology of these conditions –…